Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.

ABSTRACT:

SUBMITTER: Malekzadeh P 

PROVIDER: S-EPMC6391139 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature